Prevention of Delirium with Melatonin in ICU (multi‑arm, multi‑stage)

Phase 2, randomised, double-blind trial of melatonin in delirium, Insomnia and critical illness (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Proportion of patients with delirium between randomization and Day 14 and Pharmacokinetics of melatonin in ICU patients. Started Mar 2018; status: active.